• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

6.140 -0.100 (-1.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
April 22, 2026
From Certara
Via GlobeNewswire
News headline image
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
April 09, 2026
From Certara
Via GlobeNewswire
News headline image
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
March 03, 2026
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. 
From Certara
Via GlobeNewswire
Certara Inc (NASDAQ:CERT) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
February 26, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
 
Via Benzinga
News headline image
Certara to Participate in Upcoming Investor Conferences
February 27, 2026
From Certara
Via GlobeNewswire
News headline image
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
February 26, 2026
From Certara
Via GlobeNewswire
News headline image
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
January 29, 2026
From Certara
Via GlobeNewswire
News headline image
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence
January 05, 2026
The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The... 
Via MarketMinute
Topics Earnings
News headline image
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway ↗
January 05, 2026
Certara provides biosimulation software and regulatory solutions to global biopharma clients, supporting drug development and approvals. 
Via The Motley Fool
News headline image
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
From Certara
Via GlobeNewswire
News headline image
ArrowMark Slashes Alight Position Amid Growing Questions About Its Recurring-Revenue Strategy ↗
December 04, 2025
ArrowMark’s sharp reduction in its Alight stake comes at a moment when the market is questioning whether the company can turn its consulting-heavy work into steadier recurring revenue, and that tension... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia ↗
November 17, 2025
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Certara Reports Third Quarter 2025 Financial Results
November 06, 2025
Updates Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara Automates Scientific Workflows with Phoenix® Cloud
November 04, 2025
New cloud capabilities cut time to create Tables, Figures, and Listings by 50% 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
October 31, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Expands Biosimulation Market with AI-Driven QSP Platform
October 30, 2025
Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapies 
From Certara
Via GlobeNewswire
News headline image
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
October 10, 2025
From Certara
Via GlobeNewswire
News headline image
Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗
October 02, 2025
 
Via Benzinga
News headline image
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
September 12, 2025
 
Via Benzinga
News headline image
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
September 04, 2025
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurements 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
September 02, 2025
From Certara
Via GlobeNewswire
News headline image
Certara (CERT) Q2 Revenue Jumps 12% ↗
August 06, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Certara Reports Second Quarter 2025 Financial Results
August 06, 2025
Reiterates Full Year 2025 Financial Guidance 
From Certara
Via GlobeNewswire
News headline image
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
August 04, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
July 31, 2025
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development 
From Certara
Via GlobeNewswire
News headline image
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
July 09, 2025
From Certara
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap